Biosimilar implementation :

Biosimilar implementation : a progress report from FDA : hearing before the Subcommittee on Primary Health and Retirement Security of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, first session, on examining biosimilar implementation, focusing on a progress report from FDA, September 17, 2015. Biosimilar implementation : a progress report from Food and Drug Administration - iii, 40 pages : illustrations ; 24 cm. - S. hrg. ; 114-700 . - United States. Congress. Senate. S. hrg. ; 114-700. .

Shipping list no.: 2018-0124-M. CRDP Program record.

Includes bibliographical references.


Microfiche.
[Washington, D.C.] :
U.S. Government Printing Office,
[2017]
1 microfiche : negative.


United States. Food and Drug Administration --Rules and practice.
United States. Food and Drug Administration.


Pharmaceutical biotechnology--Management.--United States
Pharmaceutical biotechnology--Government policy--United States.
Drug development--Government policy--United States.
Drugs--Generic substitution--Government policy--United States.


United States.


Legislative hearings.
Legislative hearings.
Rules.

KF26 / .L2774 2015a

1043-B (MF)

Y 4.L 11/4:S.HRG.114-700
logopucpr-y-vive

Contáctanos

¡Queremos saber de ti!

Tel. 787.841.2000 Ext. 1801

bibliotecavaldes@pucpr.edu

⁣Búscanos en las redes

© 2026 Desarrollado por Ignite Online • All Rights Reserved • Powered by Koha.